<--- Back to Details
First PageDocument Content
Technology / Pharmacology / Clinical research / United States administrative law / United States Public Health Service / Medical device / Institutional review board / Federal Register / Premarket approval / Medicine / Health / Food and Drug Administration
Date: 2014-10-07 13:32:02
Technology
Pharmacology
Clinical research
United States administrative law
United States Public Health Service
Medical device
Institutional review board
Federal Register
Premarket approval
Medicine
Health
Food and Drug Administration

[removed]Federal Register / Vol. 79, No[removed]Friday, September 26, [removed]Notices particular diagnosis, prognosis, and monitoring or risk assessment.

Add to Reading List

Source URL: www.gpo.gov

Download Document from Source Website

File Size: 174,46 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document